A new approach to the surgical management of scleromalacia perforans is described with a Case Report on a 53-year-old lady, who was followed up for the past nine months.
YanoffMFineBS. Ocular Pathology. New York: Harper and Row inc. 1975; 317.
5.
RahiAHSGarnerA. Immunopathology of the Eye. Oxford: Blackwell Scientific Publications1976; 286.
6.
WatsonP. Disease of Sclera and Episclera. In DuaneTD. Ed. Clinical OphthalmologyPhiladelphia: Harper and Row1981; 4:11.
7.
McGavinDDM. Episcleritis and Scleritis. In BuchananWDickWC. Eds. Recent advances in Rheumatology, Part II. Edinburgh: Churchill Livingstone1976: 184.
8.
BreslinCWKatzJIKaufmanHE. Surgical management of necrotizing scleritis. Arch Ophthalm1977; 95:2038–2040.
9.
SevelDAbramsonA. Necro-granulomatous scleritis treated by an onlay scleral graft. B J Ophthalm1972; 56:791–799.
10.
TorchiaRTDunnREPeasePJ. Fascia lata grafting in scleromalacia perforans. Am J Ophth1968; 66:705–709.
11.
WinkelmannJW. Fascia Lata plasty in scleromalacia perforans. Ophthalmologica1977; 175(1):46.
12.
LangKEngelDChandlerJWAmonsWK. Allogenic Sclera: A weak immunogen or a strong suppressant? In SilversteinAMO'ConnorGR. Eds. Immunology and Immunopathology of the eye. New York: Masson1978; 180.
